A general, long standing interest of the applicant has been to understand the role(s) played by cyclic nucleotide phosphodiesterases (PDEs) in determining the amplitude and duration of second messenger cyclic nucleotide signals in the cell. It has always been clear that in order to do this one needs to know how many different PDEs are present in mammalian tissues, how and where they are expressed, and how they are regulated. Once identified and characterized it is then often possible to determine what functions are subserved by distinct PDE isozymes. This grant application outlines two phases of this process. First, we propose a continuation of our search for new PDEs and subsequent characterization of their kinetic and regulatory properties. One major difference compared to previous years is that we are now using more modern bioinformatic approaches for the initial aspects of this process. The second part of the application proposes specific examples for defining some the functions of one specific phosphodiesterase, PDE3B, as a modulator of growth factor and cytokine function in several different cell types. Specific examples include tests for the regulation by leptin stimulation of PDE3B of glucose metabolism in the liver, of cortisol synthesis in the adrenal and of feeding behavior in the hypothalamus. Similar approaches with other cytokines will also be carried out. These studies have the potential to define a whole new molecular mechanism of action for cytokines and a whole new general physiological role for PDE3B.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK021723-25
Application #
6523956
Study Section
Biochemistry Study Section (BIO)
Program Officer
Blondel, Olivier
Project Start
1978-09-15
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
25
Fiscal Year
2002
Total Cost
$335,147
Indirect Cost
Name
University of Washington
Department
Pharmacology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Temkitthawon, Prapapan; Hinds, Thomas R; Beavo, Joseph A et al. (2011) Kaempferia parviflora, a plant used in traditional medicine to enhance sexual performance contains large amounts of low affinity PDE5 inhibitors. J Ethnopharmacol 137:1437-41
Percival, Justin M; Adamo, Candace M; Beavo, Joseph A et al. (2011) Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of duchenne muscular dystrophy. Handb Exp Pharmacol :323-44
Surapisitchat, James; Beavo, Joseph A (2011) Regulation of endothelial barrier function by cyclic nucleotides: the role of phosphodiesterases. Handb Exp Pharmacol :193-210
Hertz, Angie L; Bender, Andrew T; Smith, Kimberly C et al. (2009) Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages. Proc Natl Acad Sci U S A 106:21978-83
Martinez, Sergio E; Heikaus, Clemens C; Klevit, Rachel E et al. (2008) The structure of the GAF A domain from phosphodiesterase 6C reveals determinants of cGMP binding, a conserved binding surface, and a large cGMP-dependent conformational change. J Biol Chem 283:25913-9
Poppe, Heiko; Rybalkin, Sergei D; Rehmann, Holger et al. (2008) Cyclic nucleotide analogs as probes of signaling pathways. Nat Methods 5:277-8
Askari, Bardia; Kanter, Jenny E; Sherrid, Ashley M et al. (2007) Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages. Diabetes 56:1143-52
Surapisitchat, James; Jeon, Kye-Im; Yan, Chen et al. (2007) Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3. Circ Res 101:811-8
Conti, Marco; Beavo, Joseph (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76:481-511
Laxman, Sunil; Riechers, Aaron; Sadilek, Martin et al. (2006) Hydrolysis products of cAMP analogs cause transformation of Trypanosoma brucei from slender to stumpy-like forms. Proc Natl Acad Sci U S A 103:19194-9

Showing the most recent 10 out of 76 publications